UGT2B7 Inhibitors
DBCAT004456Pharmacologic class
A DrugBank category of 15 drugs. 12 of them are approved.
What you can answer from here — as of August 09, 2019
Which targets do UGT2B7 Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account